New Pain Pill Causing Controversy Over Its Potency

Feb 26, 2014


A coalition of more than 40 health care, consumer and addiction treatment groups is asking the FDA to revoke approval of the prescription drug Zohydro. The hydrocodone-based drug is the latest in a group of painkillers called opioid analgesics. The FDA approved the medication last fall to treat chronic pain, and it is supposed to be released in March.

"In the midst of a severe drug epidemic fueled by overprescribing of opioids, the very last thing the country needs is a new, dangerous, high-dose opioid," the coalition wrote in a letter to FDA Commissioner Dr. Margaret Hamburg. Read the full story

Show Comments
Hide Comments

Join the discussion

We welcome your thoughtful comments.
All comments will display your user name.

Want to participate in the discussion?

Register for free

Log in for complete access.


No one has commented on this page yet.

RSS feed for comments on this page | RSS feed for all comments